Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet’s disease after switching from infliximab originator

Three patients affected by Behçet’s disease (BD) with severe uveitis and neurological involvement in stable clinical remission and who rapidly relapsed after switching from reference infliximab (re-IFX) to biosimilar infliximab (bio-IFX) are reported. In order to observe the rules of local health au...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Rheumatol
Hlavní autoři: Cantini, Fabrizio, Niccoli, Laura, Nannini, Carlotta, Cassarà, Emanuele, Kaloudi, Olga
Médium: Artigo
Jazyk:Inglês
Vydáno: Medical Research and Education Association 2017
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5741345/
https://ncbi.nlm.nih.gov/pubmed/29308287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2017.16112
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky